For comments, suggestions
Created with Raphaël 2.1.0 28.12.2012 Formal examination (assignment of filing date) 01.04.2013 Preliminary and substantive examination 31.08.2014 Publication of the decision of grant (B1) 28.02.2015 Completion of the opposition filing period 31.03.2015 Issuance of patent (C1) 28.12.2017 Valid until 31.07.2019 Publication of the decision of forfeiture, the term of re-establishment has expired

Patent lapsed


(11)Number of the document4300
(21)Number of the applicationa 2012 0128
(22)Filing date of the application2012.12.28
 Date of filing the request for examination (de fond) 28.12.2012
(71)Name(s) of applicant(s), code of the countryINSTITUTIA PUBLICA UNIVERSITATEA DE STAT DIN MOLDOVA, MD;
(72)Name(s) of inventor(s), code of the countryGULEA Aurelian, MD; JALBA Angela, MD; TAPCOV Victor, MD; SOVA Sergiu, MD; POIRIER Donald, CA; COTOVAIA Aliona, MD;
(73)Name(s) of owner(s), code of the countryUNIVERSITATEA DE STAT DIN MOLDOVA, MD;
(54)Title of the inventionInhibitor of HepG2 cell proliferation in liver cancer based on chloro-[2-phenyl(pyridine-2-yl)methanone-4-(3-methoxyphenyl)thiosemicarbazono]nickel
(13)Kind-of-document code
C1, BOPI 03/2015
B1, BOPI 08/2014
(51)International Patent Classification C07F 15/04 (2006.01); C07C 49/303 (2006.01); C07C 49/323 (2006.01); C07C 337/08 (2006.01); A61K 31/175 (2006.01); A61K 31/31 (2006.01); A61P 1/16 (2006.01); A61P 35/00 (2006.01);
(19)CountryMD
(45)Date of publication of patent granting decision:2014.08.31
(47)Date of issuance of patent2015.03.31
 Substantive examiner(s)IUSTIN Viorel
 Payment for maintenance up to the date2017.12.28
 Date of patent termination2017.12.28
 Date of publication of the termination of patent, with the right of restoration2018.07.31
 Date of publication of the termination of patent, without the right of restoration2019.07.31
Up
/inventions/Details.aspx?id=a%202012%200128